I8F-MC-GPGH - ClinicalTrials.gov - NCT03882970
I8F-MC-GPGH - ClinicalTrials.gov - NCT03882970
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participant must have type 2 diabetes mellitus (T2DM)
Participant must be on stable treatment dose of metformin, with or without an SGLT-2 inhibitor
Participant must be of stable weight
Participants must NOT
Participant must not have type 1 diabetes mellitus (T1DM)
Participant must not have pancreatitis
Participant must not have disorders with slowed emptying of the stomach contents, or have had any stomach surgeries for the purpose of weight loss
Participant must not have acute or chronic hepatitis or symptoms of any other liver disease
Participant must not have had a heart attack stroke, or hospitalization for congestive heart failure in the past 2 months
Participant must not have been taking weight loss drugs including over-the-counter medications during the last 3 months
Trial Summary
Conditions the trial is for
Adult Type 2 Diabetes
What the trial is testing?
Tirzepatide, Insulin Degludec
Could I receive a Placebo?
no
Enrollment Goal
1420
Trial Dates
April 2019 - January 2021
Trial Phase
3
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participant must have type 2 diabetes mellitus (T2DM)
Participant must be on stable treatment dose of metformin, with or without an SGLT-2 inhibitor
Participant must be of stable weight
Participants must NOT
Participant must not have type 1 diabetes mellitus (T1DM)
Participant must not have pancreatitis
Participant must not have disorders with slowed emptying of the stomach contents, or have had any stomach surgeries for the purpose of weight loss
Participant must not have acute or chronic hepatitis or symptoms of any other liver disease
Participant must not have had a heart attack stroke, or hospitalization for congestive heart failure in the past 2 months
Participant must not have been taking weight loss drugs including over-the-counter medications during the last 3 months
Trial Summary
Conditions the trial is for
Adult Type 2 Diabetes
What the trial is testing?
Tirzepatide, Insulin Degludec
Could I receive a Placebo?
no
Enrollment Goal
1420
Trial Dates
April 2019 - January 2021
Trial Phase
3
Trial Locations
Hide locations not currently recruiting